Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.

Yonezawa, Atsushi; Dutt, Suparna; Chester, Cariad; Kim, Jeewon; Kohrt, Holbrook E

Yonezawa, Atsushi; Dutt, Suparna; Chester, Cariad; Kim, Jeewon; Kohrt, Holbrook E.

Affiliation

Yonezawa A; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
Dutt S; Immunology and Rheumatology, Stanford University, Stanford, California.
Chester C; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, California.
Kim J; Transgenic, Knockout and Tumor Model Center, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, California.
Kohrt HE; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. kohrt@stanford.edu.

Clin Cancer Res ; 21(14): 3113-20, 2015 Jul 15.

Article de En | MEDLINE | ID: mdl-25908780

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigènes CD137 / Immunothérapie / Anticorps monoclonaux / Tumeurs Limites: Animals / Humans Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2015 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google